المؤلفون: Jang Won Son, Soo Lim

المصدر: Endocrinology and Metabolism, Vol 39, Iss 2, Pp 206-221 (2024)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic polypeptide, glucagon, multiagonist, obesity, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: http://www.e-enm.org/upload/pdf/enm-2024-1940.pdfTest; https://doaj.org/toc/2093-596XTest; https://doaj.org/toc/2093-5978Test

الوصول الحر: https://doaj.org/article/76511dc6bdf24a9cb8f6551fad04c232Test

المؤلفون: Giuliana Cimino, Muthiah Vaduganathan, Carlo M. Lombardi, Matteo Pagnesi, Enrico Vizzardi, Daniela Tomasoni, Marianna Adamo, Marco Metra, Riccardo M. Inciardi

المصدر: ESC Heart Failure, Vol 11, Iss 2, Pp 649-661 (2024)

مصطلحات موضوعية: Heart failure with preserved ejection fraction, Glucagon‐like peptide‐1 receptor agonists, Obesity, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2055-5822Test

الوصول الحر: https://doaj.org/article/4b960ada66b345948d2cb42dd058ab2aTest

المؤلفون: Qingyue Zeng, Jiao Xu, Xingyu Mu, Yi Shi, Hong Fan, Shuangqing Li

المصدر: Frontiers in Endocrinology, Vol 15 (2024)

مصطلحات موضوعية: dual agonists, incretin based therapy, tirzepatide, type 2 diabetes, obesity, glucagon-like peptide-1 receptor agonists, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2024.1342543/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/2162f9c4b2ee436eaf8b18081da08edaTest

المؤلفون: Wafa Ali Aldhaleei, Tadesse M. Abegaz, Akshaya Srikanth Bhagavathula

المصدر: Pharmaceuticals, Vol 17, Iss 2, p 199 (2024)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonists, hypoglycemic agents, cardiovascular drugs, type 2 diabetes mellitus, obesity, adverse events, Medicine, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1424-8247/17/2/199Test; https://doaj.org/toc/1424-8247Test

الوصول الحر: https://doaj.org/article/eab50e0709514a8ca9a78517d82426abTest

المؤلفون: Qingyue Zeng, Jiao Xu, Xingyu Mu, Yi Shi, Hong Fan, Shuangqing Li

المصدر: Frontiers in Endocrinology, Vol 14 (2023)

مصطلحات موضوعية: dual agonists, incretin based therapy, tirzepatide, type 2 diabetes, obesity, glucagon-like peptide-1 receptor agonists, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2023.1214334/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/9e2f093220344ebdac213a0766ebae77Test

المؤلفون: Alexandra Aponte Varnum, Edoardo Pozzi, Nicholas Allen Deebel, Aymara Evans, Nathalie Eid, Hossein Sadeghi-Nejad, Ranjith Ramasamy

المصدر: Medicina, Vol 60, Iss 1, p 50 (2023)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonists, obesity, semen parameters, male infertility, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1648-9144/60/1/50Test; https://doaj.org/toc/1010-660XTest; https://doaj.org/toc/1648-9144Test

الوصول الحر: https://doaj.org/article/567893197fb2484f8dd51532976da36aTest

المؤلفون: Cormac Kennedy, PETER HAYES, Sulafa Salama, Martina Hennessy, Federica Fogacci

مصطلحات موضوعية: Health sciences, blood pressure, hypertension, body weight, obesity, Glucagon-like peptide-1 receptor agonists (GLP-1 RA)

العلاقة: https://figshare.com/articles/journal_contribution/The_effect_of_semaglutide_on_blood_pressure_in_patients_without_diabetes_A_systematic_review_and_meta-analysis/23821833Test

الإتاحة: https://doi.org/10.34961/researchrepository-ul.23821833.v1Test
https://figshare.com/articles/journal_contribution/The_effect_of_semaglutide_on_blood_pressure_in_patients_without_diabetes_A_systematic_review_and_meta-analysis/23821833Test

المؤلفون: Lincoff, AM, Brown-Frandsen, K, Colhoun, HM, Deanfield, J, Emerson, SS, Esbjerg, S, Hardt-Lindberg, S, Hovingh, GK, Kahn, SE, Kushner, RF, Lingvay, I, Oral, TK, Michelsen, MM, Plutzky, J, Tornøe, CW, Ryan, DH

المصدر: New England Journal of Medicine , 389 (24) pp. 2221-2232. (2023)

مصطلحات موضوعية: Humans, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Double-Blind Method, Glucagon-Like Peptides, Hypoglycemic Agents, Myocardial Infarction, Obesity, Overweight, Stroke, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Cardiovascular Agents

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10184940/1/nejmoa2307563.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10184940Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10184940/1/nejmoa2307563.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10184940Test/

المؤلفون: Kennedy, Cormac, Hennessy, Martina

مصطلحات موضوعية: Blood pressure, STEP trials, Randomized controlled trials, Weight loss, Semaglutide, Hypertension, Body weight, Obesity, Glucagon-like peptide-1 receptor agonists

العلاقة: Journal of Clinical Medicine; 12; 3; Kennedy, Cormac, Hayes, Peter, Salama, Sulafa, Hennessy, Martina, Fogacci, Federica, The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis, Journal of Clinical Medicine, 12, 3, 2023, 772; Y; http://hdl.handle.net/2262/104808Test; http://people.tcd.ie/mhennessTest; http://people.tcd.ie/kennec30Test; 251551; https://doi.org/10.3390/jcm12030772Test; orcid:0000-0002-2153-5288

الإتاحة: https://doi.org/10.3390/jcm12030772Test
http://hdl.handle.net/2262/104808Test
http://people.tcd.ie/mhennessTest
http://people.tcd.ie/kennec30Test

المؤلفون: Scheen, André, DE FLINES, Jenny, Paquot, Nicolas

المصدر: Revue Médicale de Liège, 78 (3), 147-152 (2023-03)

مصطلحات موضوعية: Anti-Obesity Agents, Glucagon-Like Peptide 1, IY9XDZ35W2 (Glucose), Glucagon-Like Peptide-1 Receptor, Hypoglycemic Agents, Humans, Anti-Obesity Agents/pharmacology/therapeutic use, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide 1/pharmacology/therapeutic use, Obesity/drug therapy, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents/therapeutic use, Anorectic drugs, Gastrointestinal peptides, Glucagon-like peptide-1, Obesity, Pharmacotherapy, Safety, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie

العلاقة: urn:issn:0370-629X; urn:issn:2566-1566; https://orbi.uliege.be/handle/2268/303516Test; info:hdl:2268/303516; https://orbi.uliege.be/bitstream/2268/303516/1/AJ-Scheen_2023_78_3_0%20medic%20anti%20obesite.pdfTest; scopus-id:2-s2.0-85150313870; info:pmid:36924152

الإتاحة: https://orbi.uliege.be/handle/2268/303516Test
https://orbi.uliege.be/bitstream/2268/303516/1/AJ-Scheen_2023_78_3_0%20medic%20anti%20obesite.pdfTest